Zanamivir News
Zanamivir currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Zanamivir with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Dectova is indicated for the treatment of complicated and potentially life-threatening influenza A or B virus infection in adult and paediatric patients (aged ?6 months) when: The patient’s...
- Evidence level: L5
- Predicted indications (20):
- pyelonephritis (99.8%)
- influenza, severe, susceptibility to (99.4%)
- disorder of tyrosine metabolism (99.0%)
- teratogenic Pierre Robin syndrome (98.9%)
- disorder of phenylalanine metabolism (98.9%)
- tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria (98.4%)
- susceptibility to HIV infection (98.4%)
- dengue virus, susceptibility to (98.4%)
- legionnaire disease, susceptibility to (98.4%)
- aspergillosis, susceptibility to (98.4%)
- Schistosoma mansoni infection, susceptibility (98.3%)
- influenza (98.2%)
- cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency (98.1%)
- staphylococcus aureus infection (97.9%)
- pyogenic bacterial infections due to MyD88 deficiency (97.8%)
- acute hemorrhagic encephalitis (97.8%)
- acute necrotizing encephalitis (97.8%)
- HHV-6 encephalitis (97.8%)
- Hendra virus infection (97.8%)
- equine encephalitis (97.6%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.